Cargando…
KRAS mutation-induced EndMT of brain arteriovenous malformation is mediated through the TGF-β/BMP-SMAD4 pathway
OBJECTIVE: Somatic KRAS mutations have been identified in the majority of brain arteriovenous malformations (bAVMs), and subsequent in vivo experiments have confirmed that KRAS mutation in endothelial cells (ECs) causes AVMs in mouse and zebrafish models. Our previous study demonstrated that the KRA...
Autores principales: | Xu, Hongyuan, Huo, Ran, Li, Hao, Jiao, Yuming, Weng, Jiancong, Wang, Jie, Yan, Zihan, Zhang, Junze, Zhao, Shaozhi, He, Qiheng, Sun, Yingfan, Wang, Shuo, Cao, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359780/ https://www.ncbi.nlm.nih.gov/pubmed/36418055 http://dx.doi.org/10.1136/svn-2022-001700 |
Ejemplares similares
-
Exosomal miR‐3131 derived from endothelial cells with KRAS mutation promotes EndMT by targeting PICK1 in brain arteriovenous malformations
por: He, Qiheng, et al.
Publicado: (2023) -
Radiomics Analysis for Predicting Epilepsy in Patients With Unruptured Brain Arteriovenous Malformations
por: Zhao, Shaozhi, et al.
Publicado: (2021) -
To be EndMT or not to be, that is the question in pulmonary hypertension
por: Xiong, Jianhua
Publicado: (2015) -
GDF15 affects venous thrombosis by promoting EndMT through smad2/p-smad2 pathway
por: Li, Yeping, et al.
Publicado: (2023) -
miR-494 induces EndMT and promotes the development of HCC (Hepatocellular Carcinoma) by targeting SIRT3/TGF-β/SMAD signaling pathway
por: Zhang, Jinqian, et al.
Publicado: (2019)